Cigna Group (CI) – Research Analysts’ Weekly Ratings Changes

Posted by on Jun 10th, 2026

A number of firms have modified their ratings and price targets on shares of Cigna Group (NYSE: CI) recently:

  • 6/8/2026 – Cigna Group had its price target raised by Mizuho from $330.00 to $340.00. They now have an “outperform” rating on the stock.
  • 6/6/2026 – Cigna Group was downgraded by Wall Street Zen from “buy” to “hold”.
  • 6/3/2026 – Cigna Group had its price target lowered by Piper Sandler from $370.00 to $346.00. They now have an “overweight” rating on the stock.
  • 6/1/2026 – Cigna Group had its “hold (c)” rating reaffirmed by Weiss Ratings.
  • 5/26/2026 – Cigna Group was downgraded by Barclays PLC from “overweight” to “equal weight”. They now have a $304.00 price target on the stock, down from $310.00.
  • 5/22/2026 – Cigna Group had its price target raised by UBS Group AG from $375.00 to $400.00. They now have a “buy” rating on the stock.
  • 5/20/2026 – Cigna Group had its price target raised by Morgan Stanley from $355.00 to $361.00. They now have an “overweight” rating on the stock.
  • 5/20/2026 – Cigna Group was downgraded by Deutsche Bank Aktiengesellschaft from “buy” to “hold”. They now have a $302.00 price target on the stock, down from $303.00.
  • 5/5/2026 – Cigna Group had its price target raised by Sanford C. Bernstein from $358.00 to $371.00. They now have an “outperform” rating on the stock.
  • 5/4/2026 – Cigna Group had its price target raised by Guggenheim from $334.00 to $338.00. They now have a “buy” rating on the stock.
  • 5/4/2026 – Cigna Group had its price target raised by The Goldman Sachs Group, Inc. from $335.00 to $340.00. They now have a “buy” rating on the stock.
  • 5/1/2026 – Cigna Group was given a new $340.00 price target by Raymond James Financial, Inc..
  • 5/1/2026 – Cigna Group had its price target raised by Cantor Fitzgerald from $325.00 to $340.00. They now have an “overweight” rating on the stock.
  • 5/1/2026 – Cigna Group was given a new $337.00 price target by Robert W. Baird.
  • 5/1/2026 – Cigna Group was given a new $330.00 price target by Mizuho.
  • 5/1/2026 – Cigna Group had its price target raised by Barclays PLC from $303.00 to $310.00. They now have an “overweight” rating on the stock.
  • 5/1/2026 – Cigna Group had its price target raised by Royal Bank Of Canada from $333.00 to $337.00. They now have an “outperform” rating on the stock.
  • 5/1/2026 – Cigna Group had its price target raised by Wells Fargo & Company from $300.00 to $305.00. They now have an “equal weight” rating on the stock.
  • 4/20/2026 – Cigna Group had its price target lowered by Jefferies Financial Group Inc. from $333.00 to $330.00. They now have a “buy” rating on the stock.
  • 4/15/2026 – Cigna Group had its price target lowered by Robert W. Baird from $315.00 to $306.00. They now have an “outperform” rating on the stock.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.